felodipine has been researched along with Diabetes Mellitus, Adult-Onset in 20 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "With ramipril treatment urinary albumin creatinine ratio (14." | 6.68 | Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria. ( Hoffmann, W; Hopmeier, P; Schernthaner, G; Schnack, C, 1996) |
| "Eighteen patients with non-insulin dependent diabetes mellitus and hypertension were treated during two 4 week periods with the calcium antagonist felodipine or placebo in a double-blind, randomised, cross-over study." | 5.06 | Effects of felodipine on atrial natriuretic peptide in hypertensive non-insulin dependent diabetes mellitus. ( Brown, J; Capewell, S; Collier, A; Hajducka, C; Jeffrey, RF; Lee, MR, 1990) |
| " Felodipine is a highly selective dihydropyridine calcium antagonist effective in the treatment of hypertension." | 5.06 | A trial of the calcium antagonist felodipine in hypertensive type 2 diabetic patients. ( Capewell, S; Clarke, BF; Collier, A; Collier, R; Hajducka, C; Matthews, D; Muir, AL, 1989) |
| "Felodipine is a vascular-selective, dihydropyridine calcium antagonist previously investigated as a conventional tablet formulation administered twice daily." | 3.77 | Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders. ( Faulds, D; Todd, PA, 1992) |
| "With ramipril treatment urinary albumin creatinine ratio (14." | 2.68 | Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria. ( Hoffmann, W; Hopmeier, P; Schernthaner, G; Schnack, C, 1996) |
| "Felodipine was withdrawn and the diabetes was controlled before dental treatment was initiated." | 1.33 | Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient. ( Fay, AA; Gapski, R; Satheesh, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 14 (70.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tchernev, G | 1 |
| Khan, YH | 1 |
| Sarriff, A | 1 |
| Adnan, AS | 1 |
| Khan, AH | 1 |
| Malhi, TH | 1 |
| Jummaat, F | 1 |
| Miczke, A | 1 |
| Pupek-Musialik, D | 1 |
| Cymerys, M | 1 |
| Bryl, W | 1 |
| Kujawska-Łuczak, M | 1 |
| Bogdański, P | 1 |
| Fay, AA | 1 |
| Satheesh, K | 1 |
| Gapski, R | 1 |
| Kjellström, T | 2 |
| Blychert, E | 2 |
| Lindgärde, F | 2 |
| Cullinan, CA | 1 |
| Brady, EJ | 1 |
| Saperstein, R | 1 |
| Leibowitz, MD | 1 |
| Valle, M | 1 |
| Esteban, M | 1 |
| Rodríguez-Sasiaín, JM | 1 |
| Calvo, R | 1 |
| Aguirre, C | 1 |
| Schnack, C | 1 |
| Hoffmann, W | 1 |
| Hopmeier, P | 1 |
| Schernthaner, G | 1 |
| Chan, JC | 1 |
| Critchley, JA | 1 |
| Tomlinson, B | 1 |
| Chan, TY | 1 |
| Cockram, CS | 1 |
| Wesseling, H | 1 |
| Todd, PA | 1 |
| Faulds, D | 1 |
| Jungmann, E | 2 |
| Schumm-Draeger, PM | 2 |
| Scheuermann, EH | 2 |
| Usadel, KH | 1 |
| Capewell, S | 3 |
| Collier, A | 3 |
| Matthews, D | 2 |
| Collier, R | 2 |
| Hajducka, C | 3 |
| Clarke, BF | 2 |
| Muir, AL | 2 |
| Nickelsen, T | 1 |
| Schöffling, K | 1 |
| Jeffrey, RF | 1 |
| Brown, J | 1 |
| Lee, MR | 1 |
| Schmitz, A | 1 |
| Pedersen, MM | 1 |
| Mogensen, CE | 1 |
1 review available for felodipine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.
Topics: Angina Pectoris; Cardiomegaly; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Drug Interact | 1992 |
11 trials available for felodipine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
[The effect of analysed hypotensive drugs on certain metabolic parameters].
Topics: Adult; Antihypertensive Agents; Diabetes Mellitus, Type 2; Felodipine; Female; Humans; Hyperlipidemi | 2003 |
Short-term effects of felodipine in hypertensive type II diabetic males on sulfonylurea treatment.
Topics: Aged; Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Felo | 1994 |
Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria.
Topics: Adrenergic beta-Antagonists; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atenolol; | 1996 |
Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus.
Topics: Aged; Albuminuria; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Ca | 1997 |
[Lowering of diastolic blood pressure < or = 90 mmHg should not be attempted, except in type 2 diabetics; the 'Hypertension optimal treatment' (HOT) trial].
Topics: Adult; Aged; Aspirin; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Me | 1999 |
Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.
Topics: Angina Pectoris; Cardiomegaly; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Drug Interact | 1992 |
Felodipine in type II diabetes mellitus.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Felodipine; Female; Glucose Tol | 1990 |
Felodipine in the treatment of hypertensive type II diabetics: effect on glucose homeostasis.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Metho | 1991 |
Effects of felodipine on atrial natriuretic peptide in hypertensive non-insulin dependent diabetes mellitus.
Topics: Aged; Atrial Natriuretic Factor; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Felo | 1990 |
Effects of felodipine on urinary albumin excretion and metabolic control in hypertensive non-insulin-dependent diabetics.
Topics: Aged; Albuminuria; Blood Pressure; C-Peptide; Delayed-Action Preparations; Diabetes Mellitus, Type 2 | 1990 |
A trial of the calcium antagonist felodipine in hypertensive type 2 diabetic patients.
Topics: Apolipoproteins; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Creatinine; Diabetes Melli | 1989 |
9 other studies available for felodipine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antih | 2023 |
Complications associated with End Stage Renal Disease.
Topics: Ceftazidime; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Nephropathies; Diabetic Neuropathies | 2015 |
[Dangerous duo: hypertension and pre-diabetes--the underestimated risk].
Topics: Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type | 2003 |
Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient.
Topics: Alveolar Bone Loss; Anti-Bacterial Agents; Anticholesteremic Agents; Calcium Channel Blockers; Denta | 2005 |
Glucose-dependent alterations of intracellular free calcium by glucagon-like peptide-1(7-36amide) in individual ob/ob mouse beta-cells.
Topics: Animals; Calcium; Cyclic AMP; Diabetes Mellitus, Type 2; Felodipine; Glucagon; Glucagon-Like Peptide | 1994 |
Characteristics of serum protein binding of felodipine.
Topics: Adult; Age Factors; Aged; Antihypertensive Agents; Blood Proteins; Calcium Channel Blockers; Chronic | 1996 |
[Best antihypotensive agents for the treatment of type 2 diabetes. Ramipril, the first choice, in combination with felodipin is a sensible treatment plan].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabete | 1999 |
[Long-term antihypertensive therapy of diabetic patients with felodipine. Effects of treatment on blood pressure and kidney function parameters].
Topics: Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Felodi | 1992 |
[Long-term antihypertensive treatment in diabetes mellitus. Results with the calcium antagonist felodipine].
Topics: Adult; Aged; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Felodipine; Femal | 1991 |